Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.

Bristol JA, Djavadian R, Albright ER, Coleman CB, Ohashi M, Hayes M, Romero-Masters JC, Barlow EA, Farrell PJ, Rochford R, Kalejta RF, Johannsen EC, Kenney SC.

PLoS Pathog. 2018 Jul 27;14(7):e1007179. doi: 10.1371/journal.ppat.1007179. eCollection 2018 Jul.

2.

Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells.

Weng C, Lee D, Gelbmann CB, Van Sciver N, Nawandar DM, Kenney SC, Kalejta RF.

J Virol. 2018 Jul 31;92(16). pii: e00903-18. doi: 10.1128/JVI.00903-18. Print 2018 Aug 15.

PMID:
29848590
3.

HCMV Assembly Is Totally Tubular.

Lyon SM, Kalejta RF.

Dev Cell. 2018 Apr 9;45(1):1-2. doi: 10.1016/j.devcel.2018.03.014.

PMID:
29634930
4.

Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk).

Umaña AC, Iwahori S, Kalejta RF.

ACS Chem Biol. 2018 Jan 19;13(1):189-199. doi: 10.1021/acschembio.7b00972. Epub 2017 Dec 19.

PMID:
29215867
5.
6.

Human Cytomegalovirus-Infected Glioblastoma Cells Display Stem Cell-Like Phenotypes.

Liu C, Clark PA, Kuo JS, Kalejta RF.

mSphere. 2017 Jun 21;2(3). pii: e00137-17. doi: 10.1128/mSphere.00137-17. eCollection 2017 May-Jun.

7.

Gender parity trends for invited speakers at four prominent virology conference series.

Kalejta RF, Palmenberg AC.

J Virol. 2017 Jun 7. pii: JVI.00739-17. doi: 10.1128/JVI.00739-17. [Epub ahead of print]

8.

Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.

Iwahori S, Umaña AC, VanDeusen HR, Kalejta RF.

J Biol Chem. 2017 Apr 21;292(16):6583-6599. doi: 10.1074/jbc.M116.773150. Epub 2017 Mar 13.

9.

Mouse Tmem135 mutation reveals a mechanism involving mitochondrial dynamics that leads to age-dependent retinal pathologies.

Lee WH, Higuchi H, Ikeda S, Macke EL, Takimoto T, Pattnaik BR, Liu C, Chu LF, Siepka SM, Krentz KJ, Rubinstein CD, Kalejta RF, Thomson JA, Mullins RF, Takahashi JS, Pinto LH, Ikeda A.

Elife. 2016 Nov 15;5. pii: e19264. doi: 10.7554/eLife.19264.

10.

Sifting and Winnowing through Human Cytomegalovirus Lytic Replication and Latency.

Kalejta RF.

PLoS Pathog. 2016 Sep 22;12(9):e1005607. doi: 10.1371/journal.ppat.1005607. eCollection 2016 Sep. No abstract available.

11.
12.

Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency.

Lee SH, Caviness K, Albright ER, Lee JH, Gelbmann CB, Rak M, Goodrum F, Kalejta RF.

J Virol. 2016 Sep 29;90(20):9483-94. doi: 10.1128/JVI.01547-16. Print 2016 Oct 15.

13.

Human Cytomegalovirus Can Procure Deoxyribonucleotides for Viral DNA Replication in the Absence of Retinoblastoma Protein Phosphorylation.

Kuny CV, Kalejta RF.

J Virol. 2016 Sep 12;90(19):8634-43. doi: 10.1128/JVI.00731-16. Print 2016 Oct 1.

14.

Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein.

Lee SH, Albright ER, Lee JH, Jacobs D, Kalejta RF.

Sci Adv. 2015 Nov 27;1(10):e1501164. doi: 10.1126/sciadv.1501164. eCollection 2015 Nov.

15.
16.

Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.

Iwahori S, Hakki M, Chou S, Kalejta RF.

J Biol Chem. 2015 Aug 7;290(32):19666-80. doi: 10.1074/jbc.M115.660043. Epub 2015 Jun 21.

17.

The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replication.

VanDeusen HR, Kalejta RF.

J Virol. 2015 May;89(9):5012-21. doi: 10.1128/JVI.00175-15. Epub 2015 Feb 18.

18.

The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms.

Winkler LL, Kalejta RF.

J Virol. 2014 Oct;88(20):11782-90. doi: 10.1128/JVI.01720-14. Epub 2014 Jul 30.

19.
20.

Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.

Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC.

J Virol. 2013 Sep;87(18):10126-38. doi: 10.1128/JVI.01671-13. Epub 2013 Jul 10.

Supplemental Content

Loading ...
Support Center